AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 6 analysts with an average price target of $10.17. This is a potential upside of $4.75 (87.64%) from yesterday's end of day stock price of $5.42.

Aquestive Therapeutics's activity chart (see below) currently has 53 price targets and 79 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.17% with an average time for these price targets to be met of 81.63 days.

Highest price target for AQST is $10, Lowest price target is $7, average price target is $8.33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 17-Jun-2025. First documented stock forecast 20-Aug-2018.

Currently out of the existing stock ratings of AQST, 35 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$4.58 (84.50%)

$10

2 months 20 days ago
(17-Jun-2025)

8/30 (26.67%)

$6.65 (198.51%)

290

Buy

$7

$1.58 (29.15%)

$9

3 months 4 days ago
(02-Jun-2025)

5/7 (71.43%)

$4.19 (149.11%)

259

Buy

$7

$1.58 (29.15%)

$12

3 months 4 days ago
(02-Jun-2025)

0/3 (0%)

$4.19 (149.11%)

Buy

$10

$4.58 (84.50%)

$7

10 months ago
(06-Nov-2024)

1/7 (14.29%)

$4.93 (97.24%)

52

Buy

$9

$3.58 (66.05%)

$9

10 months 29 days ago
(08-Oct-2024)

0/10 (0%)

$4.08 (82.93%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 81.63 days on average for the stock forecasts to be realized with a an average price target met ratio 17.17

Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Randall Stanicky with highest potential upside - $6.11

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Gary Nachman with lowest potential downside - $1.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?